BlackRock Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BFA
O
TCM
CCA
BIT
BlackRock Investment Management's RGEN Position: Q4 2016 in Review
BlackRock Investment Management increased its Repligen (RGEN) stake by 22% in Q4 2016, buying an estimated $959K and bringing the position to 171,279 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1560.
BlackRock Investment Management first reported a position in RGEN in Q2 2013 and has held it in 15 quarters since. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2016.
- BlackRock Investment Management held 171,279 shares of Repligen worth $5.28M as of Q4 2016.
- BlackRock Investment Management bought 31,004 Repligen shares in Q4 2016, an estimated $959K.
- Repligen made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1560 holding.
- BlackRock Investment Management first reported a position in Repligen in Q2 2013 and has held it in 15 quarters since.
- 184 funds tracked by Wall St. Rank held Repligen as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.